Two phase 3 trials of bimekizumab for the treatment of moderate-to-severe hidradenitis suppurativa: a critically appraised research paper.
Loading...
Authors
Contact
Check for full-text access
Issue Date
Type
Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Publisher
License
Journal
The British journal of dermatology